In recent years, the globalisation of clinical trials has increased for a variety of reasons. One of the most important reasons for the growth is the requirement to access patient populations within high-growth markets. Sue Miles at AndersonBrecon analyses what pharmaceutical companies should do achieve a successful trial in this global platform.
 
http://jforcs.com/jcs/wp-content/uploads/2013/06/14.-Clinical-Trials-Logistics-and-the-Globalisation-of-Clinical-Trials.pdf